Drug profile · INN
fam-trastuzumab deruxtecan-nxki
ENHERTU
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
fam-trastuzumab deruxtecan-nxki (ENHERTU) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN fam-trastuzumab deruxtecan-nxki
Brand ENHERTU
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is fam-trastuzumab deruxtecan-nxki?
fam-trastuzumab deruxtecan-nxki (ENHERTU) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for fam-trastuzumab deruxtecan-nxki?
ENHERTU is a marketed brand name for fam-trastuzumab deruxtecan-nxki. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fam-trastuzumab deruxtecan-nxki?
fam-trastuzumab deruxtecan-nxki has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.